GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ApicHope Pharmaceutical Co Ltd (SZSE:300723) » Definitions » 3-Year Revenue Growth Rate

ApicHope Pharmaceutical Co (SZSE:300723) 3-Year Revenue Growth Rate : 13.80% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ApicHope Pharmaceutical Co 3-Year Revenue Growth Rate?

ApicHope Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥1.37.

During the past 12 months, ApicHope Pharmaceutical Co's average Revenue per Share Growth Rate was -3.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 13.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of ApicHope Pharmaceutical Co was 16.50% per year. The lowest was -2.30% per year. And the median was 6.40% per year.


Competitive Comparison of ApicHope Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, ApicHope Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ApicHope Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ApicHope Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where ApicHope Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.



ApicHope Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


ApicHope Pharmaceutical Co  (SZSE:300723) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


ApicHope Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of ApicHope Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ApicHope Pharmaceutical Co (SZSE:300723) Business Description

Traded in Other Exchanges
N/A
Address
Tianhe District Zhujiang New City Jinsui Road, 17th Floor, Star International Building, Guangdong Province, Guangzhou, CHN, 510623
ApicHope Pharmaceutical Co Ltd is a fully integrated, research-oriented pharmaceutical and healthcare company. It is engaged in the research and development, production, and sale of pharmaceutical products. The company focuses on pediatric diseases, recombinant vaccines and chronic diseases.
Executives
Yang De Ming Independent director
Zhang Ming Yuan Secretary Dong
Zhang Ying Ying Supervisors
Li Han Dong Director
Ke Rui Yu Supervisors
Zhang Hui Xing Executives

ApicHope Pharmaceutical Co (SZSE:300723) Headlines

No Headlines